Enhanced sensitisation of mice with diphtheria tetanus acellular pertussis vaccine to local swelling reaction to the booster immunisation

Vaccine

Volumn 20, Issue 25-26, 2002, Pages 3088-3094

  Yamamoto, Akihiko ^a   Nagata, Noriyo ^a   Ochiai, Masaki ^a   Kataoka, Michiyo ^a   Toyoizumi, Hiromi ^a   Okada, Kenji ^b   Horiuchi, Yoshinobu ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b Minamifukuoka National Sanatorium   (Japan)

Author keywords

Animal model; Diphtheria; Local reaction; Pertussis vaccine; Tetanus

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; DIPHTHERIA TOXIN; INDOMETACIN; PERTUSSIS TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG SAFETY; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; ANIMAL; BAGG ALBINO MOUSE; BORDETELLA PERTUSSIS; EDEMA; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION;

ANIMAL; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BORDETELLA PERTUSSIS; DIPHTHERIA TOXIN; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; EDEMA; FEMALE; IMMUNIZATION; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INDOMETHACIN; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; PERTUSSIS TOXIN; SUPPORT, NON-U.S. GOV'T; ANIMALS;

EID: 0037135670     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00290-6     Document Type: Article

References (30)

1. Japan's experience in pertussis epidemiology and vaccination in the past 30 years
2. Results with a new DTP vaccine in Japan
3. Pertussis vaccines in Japan
4. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children
5. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in 4- to 6-year-old children
6. Adverse reactions and antibody response to four doses of acellular or whole cell pertussis-vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life
7. Immunogenicity and reactogenicity of a bicomponent and a tricomponent acellular pertussis-diphtheria-tetanus (DTaP) vaccine in primary immunization and as second year booster: A double-blind randomised trial
8. Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at 14-28 months of age
9. Antibody and cell-mediated immune response to booster immunization with a new acellular pertussis vaccine in school children
10. Rapid purification of Bordetella pertussis toxin by alternating affinity and hydrophobic chromatography
11. Overview of currently available Japanese acellular pertussis vaccines and future problems
12. Further evaluation of the pertussis component vaccine produced by apoceruloplasmin affinity chromatography
13. Toxicity and toxicity testing of pertussis vaccine
14. Dual effects of pertussis toxin on murine neutrophils in vivo
15. Microtiter enzyme-linked immunosorbent assay for diphtheria antitoxin in human sera - Application of parallel line assay method
16. Homologous passive cutaneous anaphylaxis (PCA) in mice and heterogous PCA induced in rats with mouse IgE
17. Determination of the histamine sensitising unitage of pertusiss vaccine
18. A sensitive assay method for the histamine-sensitive factor using change in rectal temperature of mice after histamine challenge as a response
19. A curious histamine-sensitising activity shown by the newly developed Japanese acelullar pertusiss vaccine
20. Two different histamine-sensitising activities of pertusiss vaccine observed in mice on the 4th and 12th days of sensitisation
21. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: Adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28
22. Comparison of antibody titers in 11- to 12-year old Japanese school children 6 years after administration of acellular and whole cell pertussis vaccines combined with diphtheria-tetanus toxoids
23. A comparison of young and aged populations for the diphtheria and tetanus antitoxin titers in Japan
24. Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine8 in infancy
25. A comparative trial of the reactogenicity and immunogenicity of Takeda acellular pertussis vaccine combined with tetanus and diphtheria toxoids. Outcome in 3- to 8-month-old infants, 9- to 23-month-old infants and children, and 24- to 30-month-old children
26. Modulation of delayed-type hypersensitivity during the time course of immune response to a protein antigen
27. Time course and histological differences between sheep red blood cells and tuberculin DTH reactions in mice